Impact Funding Resources
SPARK NS invites principal investigators with promising discoveries in Parkinson's disease or autism to apply for the SPARK NS Translational Research Program, 2026 Cohort. Projects selected will receive up to $2,000,000 in milestone-based funding, education, mentoring, and networking opportunities over two years, beginning January 2026
Start Date02 Jun 2025 End Date11 Jul 2025 Funding AmountUpto USD 2mn Funding Resource TypeResearch Grant
Funding ProviderSPARK NS
Research Grant
SPARK NS
Call for Proposals
https://sparkns.org/call-for-proposals.pdf
Program Description and Application Guidelines
https://sparkns.org/program-description-and-application-guidelines.pdf
SPARK NS supports translational research projects at any stage of development between target identification and entry into clinical trials. Our program focuses on Parkinson’s disease and autism.
SPARK NS accepts applications from biomedical researchers at academic or nonprofit research institutions in the United States, Canada, the United Kingdom, and Europe. We value diversity and are committed to creating a collaborative and inclusive research environment. Applicants from all backgrounds and experiences are encouraged to apply.
Applications are evaluated on the following criteria:
• Clinical need. Projects must clearly define an unmet clinical need.
• Underlying biology/technology. Projects must have a robust and novel approach that will lead to a first-in-class therapeutic.
• Feasibility of translational objectives. Projects must have translational objectives with a high probability of being accomplished during the two years of participation in the program.
